PF-Atlas › Clinical Trials › NCT05984992

The First-in-human Study of SRN-001 in Healthy Participants

SRN-001 · Phase 1

Registry ID

NCT05984992

Phase

Phase 1

Status

Completed

Drug / intervention

SRN-001

Sponsor

siRNAgen Therapeutics Inc.

Start

2023-09-08

About this trial

SRN-001 is evaluated in NCT05984992, a Phase 1 idiopathic pulmonary fibrosis study sponsored by siRNAgen Therapeutics Inc.. Current status: Completed.

View NCT05984992 on ClinicalTrials.gov →

Explore related

All SRN-001 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT05984992 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.